Competition Quote by Scott Gottlieb
“The higher cost of getting a generic drug approved by regulators means that many old medicines don't face competitors. It's only after substantial price hikes that these drugs offer enough revenue to offset the rising generic entry costs, and start to entice competition.”
About This Quote
Source Speech: Interview on Pharmaceutical Policy, 2023
High regulatory costs keep old drugs from competition, allowing price hikes before generics become viable, limiting market entry.
In simple terms: Regulation makes drug competition expensive, so prices stay high.
Key Takeaway
Recognize the impact of regulation on drug pricing.
Themes
pharmacy economics
regulation
competition
pricing
innovation
Mood
concerned
analytical
Type
policy
economic
industry.
When to use this quote
- Health policy makers
- pharma executives
- patient advocacy groups
- investors
- regulators
Key Concepts
Market entry barriers
price elasticity
public health policy
Questions to Reflect On
- How can policy balance safety with competition?
- What incentives could lower entry costs for generics?
A Different Perspective
Regulatory costs may also protect safety and incentivize R&D.
